Skip to main content
Premium Trial:

Request an Annual Quote

David Smoller, Gregory Landes, Mary-Claire King, Gordon Binder, Suzanne Mattingly


David Smoller has become vice president for research and development at Sigma-Aldrich, the company said last week. He joins Sigma-Aldrich from St. Louis-based ProteoPlex, where he was CEO and president. Prior to that, he founded Genome Systems, which was acquired by Incyte in 1996. Smoller holds a PhD in molecular biology and a bachelor’s degree in biology from Emory University.

Gregory Landes has joined Lexicon Genetics as vice president of biotherapeutics, the company, based in The Woodlands, Texas, said last week. In the past, he was vice president of product discovery at Abgenix and vice president of genetics and genomics at Genzyme. Landes holds a PhD in biochemistry and a BA in chemistry from the University of Kansas.

Mary-Claire King has won the 2004 Genetics Prize of the Peter Gruber Foundation, the foundation said last week. King, who located the BRCA1 breast cancer gene, is a professor at the University of Washington school of medicine. She holds a PhD in genetics from the University of California Berkeley and a BA in mathematics from Carleton College. King will receive the prize, which comes with $200,000, at the American Society of Human Genetics in Toronto, Canada, on Oct. 27.

Gordon Binder has joined the board of directors of Cellular Genomics, the Branford, Conn.-based company said last week He assumed his post after the company completed a Series C financing round this week. Binder is a founder and managing director of Coastview Capital. Prior to that, he was CEO of Amgen. Binder holds an MBA from Harvard Business School and a bachelor’s in electrical engineering from Purdue University.

Suzanne Mattingly joins Exagen Diagnostics of Albuquerque, NM, as vice president of business development and marketing. Mattingly most recently was vice president, marketing, at Fast Track Systems. She holds a PhD in microbiology from the Medical College of Virginia.


The Scan

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.

Effectiveness May Decline, Data From Israel Suggests

The New York Times reports that new Israeli data suggests a decline in Pfizer-BioNTech SARS-CoV-2 vaccine effectiveness against Delta variant infection, though protection against severe disease remains high.

To See Future Risk

Slate looks into the use of polygenic risk scores in embryo screening.

PLOS Papers on Methicillin-Resistant Staphylococcus, Bone Marrow Smear Sequencing, More

In PLOS this week: genomic analysis of methicillin-resistant Staphylococcus pseudintermedius, archived bone marrow sequencing, and more.